pamidronate has been researched along with Sclerosis, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbone, LD | 1 |
| Warrington, KJ | 1 |
| Barrow, KD | 1 |
| Pugazhenthi, M | 1 |
| Watsky, MA | 1 |
| Somes, G | 1 |
| Ingels, J | 1 |
| Postlethwaite, AE | 1 |
1 other study available for pamidronate and Sclerosis, Systemic
| Article | Year |
|---|---|
Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.
Topics: Aged; Cells, Cultured; Cytokines; Diphosphonates; Drug Evaluation; Female; Humans; Leukocytes, Monon | 2006 |